Elevai Labs Inc.
13F holders, Q3 2024 (September 30)8holders +4
7new positions
3sold out
$0.08avg. 13F price*
At the end of Q3 2024, 8 institutions reported holding Elevai Labs Inc. in their 13F filings, up 4 from Q2 2024. 7 opened new positions and 3 sold out. The largest holders were Sabby Management, LLC ($211K), Geode Capital Management, LLC ($4K) and Two Sigma Securities, LLC ($4K).
- Company
- Elevai Labs Inc.
- CUSIP
- 28622K104
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $226K |
| Exits | 3 | $57K |
All 13F filers, Q2 2024 → Q3 2024: 2,728,923 shares bought and 126,811 shares sold, net +2,602,112 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 8 holders
| Sabby Management, LLC | 2.93% | New | 2,541,779 | $211K |
| Geode Capital Management, LLC | 0.00% | New | 45,130 | $4K |
| Two Sigma Securities, LLC | 0.00% | New | 43,265 | $4K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 39,128 | $3K |
| Diversify Advisory Services, LLC | 0.00% | Reduce -52.4% | 25,000 | $3K |
| HRT Financial LP | 0.00% | New | 35,853 | $2K |
| Susquehanna International Group, LLP | 0.00% | New | 23,602 | $2K |
| Bank of America Corp. | 0.00% | New | 166 | $13 |
"% of holder's portfolio" is ELEVAI LABS INC's weight in each manager's 13F, not the share of Elevai Labs Inc. the manager owns.